Skip to content
healthcare.dev

Rivastigmine Tartrate

NDC 65862-651, Rivastigmine Tartrate, capsule, from Aurobindo Pharma Limited.

Product NDC
65862-651
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204572
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-651 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE TARTRATE6 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
65862-651-0565862065105500 CAPSULE in 1 BOTTLE (65862-651-05)
65862-651-606586206516060 CAPSULE in 1 BOTTLE (65862-651-60)
65862-651-786586206517810 BLISTER PACK in 1 CARTON (65862-651-78) / 10 CAPSULE in 1 BLISTER PACK (65862-651-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c246a0e5-1e77-41ee-a7b3-384f21f2f2e0
  • NADAC price for package 65862065160

    GET /v1/drugs/nadac/65862065160

Use it

Look up 65862-651 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-651 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-651. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.